Overview of Radiation Therapy for Treating Rectal Cancer
A major outcome of importance for rectal cancer is local control. Parallel to improvements in surgical technique, adjuvant therapy regimens have been tested in clinical trials in an effort to reduce the local recurrence rate. Nowadays, the local recurrence rate has been reduced because of both good...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
The Korean Society of Coloproctology
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155135/ |
| id |
pubmed-4155135 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-41551352014-09-10 Overview of Radiation Therapy for Treating Rectal Cancer Kye, Bong-Hyeon Cho, Hyeon-Min Review A major outcome of importance for rectal cancer is local control. Parallel to improvements in surgical technique, adjuvant therapy regimens have been tested in clinical trials in an effort to reduce the local recurrence rate. Nowadays, the local recurrence rate has been reduced because of both good surgical techniques and the addition of radiotherapy. Based on recent reports in the literature, preoperative chemoradiotherapy is now considered the standard of care for patients with stages II and III rectal cancer. Also, short-course radiotherapy appears to provide effective local control and the same overall survival as more long-course chemoradiotherapy schedules and, therefore, may be an appropriate choice in some situations. Capecitabine is an acceptable alternative to infusion fluorouracil in those patients who are able to manage the responsibilities inherent in self-administered, oral chemotherapy. However, concurrent administration of oxaliplatin and radiotherapy is not recommended at this time. Radiation therapy has long been considered an important adjunct in the treatment of rectal cancer. Although no prospective data exist for several issues, we hope that in the near future, patients with rectal cancer can be treated by using the best combination of surgery, radiation therapy, and chemotherapy in near future. The Korean Society of Coloproctology 2014-08 2014-08-26 /pmc/articles/PMC4155135/ /pubmed/25210685 http://dx.doi.org/10.3393/ac.2014.30.4.165 Text en © 2014 The Korean Society of Coloproctology http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Kye, Bong-Hyeon Cho, Hyeon-Min |
| spellingShingle |
Kye, Bong-Hyeon Cho, Hyeon-Min Overview of Radiation Therapy for Treating Rectal Cancer |
| author_facet |
Kye, Bong-Hyeon Cho, Hyeon-Min |
| author_sort |
Kye, Bong-Hyeon |
| title |
Overview of Radiation Therapy for Treating Rectal Cancer |
| title_short |
Overview of Radiation Therapy for Treating Rectal Cancer |
| title_full |
Overview of Radiation Therapy for Treating Rectal Cancer |
| title_fullStr |
Overview of Radiation Therapy for Treating Rectal Cancer |
| title_full_unstemmed |
Overview of Radiation Therapy for Treating Rectal Cancer |
| title_sort |
overview of radiation therapy for treating rectal cancer |
| description |
A major outcome of importance for rectal cancer is local control. Parallel to improvements in surgical technique, adjuvant therapy regimens have been tested in clinical trials in an effort to reduce the local recurrence rate. Nowadays, the local recurrence rate has been reduced because of both good surgical techniques and the addition of radiotherapy. Based on recent reports in the literature, preoperative chemoradiotherapy is now considered the standard of care for patients with stages II and III rectal cancer. Also, short-course radiotherapy appears to provide effective local control and the same overall survival as more long-course chemoradiotherapy schedules and, therefore, may be an appropriate choice in some situations. Capecitabine is an acceptable alternative to infusion fluorouracil in those patients who are able to manage the responsibilities inherent in self-administered, oral chemotherapy. However, concurrent administration of oxaliplatin and radiotherapy is not recommended at this time. Radiation therapy has long been considered an important adjunct in the treatment of rectal cancer. Although no prospective data exist for several issues, we hope that in the near future, patients with rectal cancer can be treated by using the best combination of surgery, radiation therapy, and chemotherapy in near future. |
| publisher |
The Korean Society of Coloproctology |
| publishDate |
2014 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155135/ |
| _version_ |
1613131150007468032 |